ѻý

Elmo's Wellness Check; Med Schools Overlook Training on Suicide; Religious Trauma

<ѻý class="mpt-content-deck">— News and commentary from the psychiatry world
MedpageToday
Illustration of a brain shaped maze.

on X opened up a tidal wave of mental health despair on the social media platform. (NBC News)

In a randomized trial of women with prenatal depression, administration of early in the postpartum period significantly reduced the incidence of postpartum depression. (JAMA Network Open)

Medical schools don't do enough to , including how to assess and identify suicidal patients, several healthcare academicians said. (Washington Post)

More than one in 10 people ages 5 to 24 years -- accounting for 293 million people globally -- had in 2019, and 1.2% had a substance use disorder. (JAMA Psychiatry)

The FDA cleared Magstim's , the Horizon 3.0 with StimGuide Pro, to treat patients diagnosed with depressive or obsessive-compulsive conditions, the company announced.

In other FDA news, the agency of one lot of dextroamphetamine (Zenzedi) tablets, a drug indicated for ADHD and narcolepsy, after a pharmacist reported finding an antihistamine in the bottle instead of dextroamphetamine.

This man would rather live on the street than . (New York Times)

Use of alcohol, cannabis, and nicotine among high schoolers each showed dose-dependent associations with (JAMA Pediatrics)

Researchers are studying can help treat serious mental illness. (NPR)

had an 82% higher risk of all-cause mortality, driven by both natural and unnatural causes, compared with those unaffected. (The BMJ)

Some psychiatrists want , an experience common to millions of LGBTQ Americans, as a mental disorder. (NBC News)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.